Tag: genomics
-
Synthetic Bio Company Goes Public in $2.5B Merger
A company developing synthetic biology and engineering tools for biotechnology is becoming a public company through a special-purpose acquisition.
-
MD Anderson, Broad Institute Partner on Rare Cancers
MD Anderson Cancer Center and the Broad Institute are developing a new research platform for better understanding rare types of cancer.
-
New Biotech Developing Synthetic Long-Term RNA
A new enterprise, created by a life science venture capital company, began work on developing therapies with long-acting synthetic RNA.
-
Biotechs Partner on Gene-Edited Cancer Cell Therapies
Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immune-system cells to treat cancer.
-
AI Gene Therapy Platform Gains $100M in Early Funds
A company using machine learning to create engineered viruses to deliver gene therapies is raising $100 million in its first venture funding round.
-
Cell Therapy Mfring Company Raises $82M in Venture Funds
A company developing an automated yet personalized manufacturing platform for cell therapies is raising $82 million in its second venture funding round.
-
Biomanufacturing Materials Company Issues $500M IPO
Zymergen Inc., a developer of materials made with synthetic biology for industrial products is raising $500 million in its initial public stock offering.
-
Trials Adding Covid-19 Hospital, Out-Patient Therapies
National Institutes of Health is adding a new treatment to a clinical trial for Covid-19 patients hospitalized with severe respiratory failure.
-
Start-Up Designing Synthetic DNA for Gene Therapies
A new biotechnology company is underway creating gene therapies for inherited diseases delivered with synthetic DNA instead of benign viruses.
-
AI Drug Discovery Company Acquired in $270M Deal
A biotechnology company using protein dynamics to develop precision cancer therapies is acquiring a drug discovery company based on machine learning algorithms.